Zymeworks
ZYME
$8.76
Share price
2.10%
Change (1 day)
3.91%
Change (1 year)
Categories
Zymeworks (ZYME) - Cash on Hand
Cash on Hand as of December 2023 : $0.37 B
According to Zymeworks's latest financial reports the company has $0.37 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Zymeworks - Cash on Hand chart (from 2016 to 2021)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.37 B | -23.95% |
| 2022-12-31 | $0.49 B | 148.34% |
| 2021-12-31 | $0.19 B | -53.51% |
| 2020-12-31 | $0.42 B | 42.64% |
| 2019-12-31 | $0.29 B | 49.33% |
| 2018-12-31 | $0.20 B | 127.99% |
| 2017-12-31 | $87.79 M | 118.07% |
| 2016-12-31 | $40.26 M | 165.57% |
| 2015-12-31 | $15.16 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -44.38% | 🇺🇸 USA |